BR100 Increased By (0.59%)
BR30 Increased By (0.78%)
KSE100 Increased By (0.39%)
KSE30 Increased By (0.41%)
BECO 6.10 Increased By ▲ 0.33 (5.72%)
BML 52.62 Decreased By ▼ -0.38 (-0.72%)
BOP 34.38 Increased By ▲ 0.39 (1.15%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.26 Increased By ▲ 0.43 (0.81%)
FCSC 5.13 Increased By ▲ 0.06 (1.18%)
FFL 18.05 Increased By ▲ 0.10 (0.56%)
FNEL 1.31 Increased By ▲ 0.02 (1.55%)
HUMNL 10.86 Decreased By ▼ -0.02 (-0.18%)
KEL 8.14 Increased By ▲ 0.12 (1.5%)
KOSM 5.27 Decreased By ▼ -0.25 (-4.53%)
MLCF 87.05 Increased By ▲ 0.54 (0.62%)
NBP 187.01 Increased By ▲ 1.85 (1%)
PACE 10.62 Increased By ▲ 0.04 (0.38%)
PAEL 39.85 Increased By ▲ 0.43 (1.09%)
PIAHCLA 26.11 Decreased By ▼ -0.11 (-0.42%)
PIBTL 17.34 Increased By ▲ 0.67 (4.02%)
PPL 229.27 Increased By ▲ 1.09 (0.48%)
PRL 34.75 Increased By ▲ 0.07 (0.2%)
PTC 66.97 Increased By ▲ 1.64 (2.51%)
SEARL 90.75 Increased By ▲ 0.62 (0.69%)
SSGC 26.95 Increased By ▲ 0.35 (1.32%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 58.80 Increased By ▲ 0.30 (0.51%)
TPLP 8.65 Increased By ▲ 0.43 (5.23%)
TREET 24.51 Decreased By ▼ -0.02 (-0.08%)
TRG 69.73 Increased By ▲ 0.02 (0.03%)
WAVES 9.95 Increased By ▲ 0.01 (0.1%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
Topic

BioNtech vaccine

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

Published 04 May, 2021 05:41pm
  • "Our first formulation had to be stored and shipped at minus 80 degrees. We have now, in the meantime, a formulation which is not yet approved... which can be stored at two to eight degrees," Sahin told a Financial Times conference panel, adding that data packages were being prepared for regulators.
Erdogan says Turkey expects more COVID-19 vaccine supplies soon

Erdogan says Turkey expects more COVID-19 vaccine supplies soon

Published 30 Apr, 2021 06:05pm
  • Turkey has so far been using vaccines developed by China's Sinovac Biotech Ltd and by Pfizer and BioNTech .
  • It has carried out nearly 23 million inoculations, with 13.7 million people, or 16% of the population, having received at least one dose.
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Published 30 Apr, 2021 04:51pm
  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
EU preparing orders for 1.8bn vaccine booster shots

EU preparing orders for 1.8bn vaccine booster shots

Published 09 Apr, 2021 06:54pm
  • The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
  • Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Europe to get 4mn more Pfizer/BioNTech COVID-19 shots this month

Europe to get 4mn more Pfizer/BioNTech COVID-19 shots this month

Updated 10 Mar, 2021 07:24pm
  • The doses to vaccinate two million people will be supplied in addition to the planned deliveries, to ease border movement and to tackle virus hotspots, the Commission said.
  • "To tackle aggressive variants of the virus and to improve the situation in hotspots, quick and decisive action is necessary," the president of the Commission, Ursula von der Leyen, said.
What you need to know about the coronavirus right now

What you need to know about the coronavirus right now

Published 11 Feb, 2021 12:35pm
  • The airline said pilots and cabin crew on three international flights from Singapore to Jakarta, Bangkok and Phnom Penh had received both of the required doses of the Pfizer-BioNTech vaccine.
Britain has given 10 million people a first COVID-19 vaccine dose

Britain has given 10 million people a first COVID-19 vaccine dose

Published 03 Feb, 2021 09:15pm
  • "This is a hugely significant milestone in our national effort against this virus."
  • The country approved vaccines developed by Pfizer-BioNTech and Oxford University-AstraZeneca earlier than the United States and Europe, enabling it to make an early start on roll-out.
BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

Published 02 Feb, 2021 06:47pm
  • Japan's vaccine chief said last week that export controls imposed by the European Union, where some vaccines are made, could delay the Asian nation's inoculation effort.
  • Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.
EU repeats Pfizer/BioNTech to deliver 75mn extra vaccine doses in Q2

EU repeats Pfizer/BioNTech to deliver 75mn extra vaccine doses in Q2

Published 01 Feb, 2021 06:36pm
  • BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year - and up to 600 millions in total in 2021.
  • BioNTech and Pfizer this month raised their supply goal for this year to 2 billion doses, up from a previous aim of 1.3 billion.
EU set to require authorisation for vaccine exports

EU set to require authorisation for vaccine exports

Published 28 Jan, 2021 09:17pm
  • The Commission, which has coordinated the orders, said on Tuesday it would propose that pharmaceutical firms be required to register their vaccine exports.
  • The decision will be taken tomorrow to start implementing this mechanism.
Loading...